Literature DB >> 28600802

mTORC1 and mTORC2 as regulators of cell metabolism in immunity.

Monika Linke1, Stephanie Deborah Fritsch1, Nyamdelger Sukhbaatar1, Markus Hengstschläger1, Thomas Weichhart1.   

Abstract

The mechanistic target of rapamycin (mTOR) pathway is an evolutionarily conserved signaling pathway that senses intra- and extracellular nutrients, growth factors, and pathogen-associated molecular patterns to regulate the function of innate and adaptive immune cell populations. In this review, we focus on the role of the mTOR complex 1 (mTORC1) and mTORC2 in the regulation of the cellular energy metabolism of these immune cells to regulate and support immune responses. In this regard, mTORC1 and mTORC2 generally promote an anabolic response by stimulating protein synthesis, glycolysis, mitochondrial functions, and lipid synthesis to influence proliferation and survival, effector and memory responses, innate training and tolerance as well as hematopoietic stem cell maintenance and differentiation. Deactivation of mTOR restores cell homeostasis after immune activation and optimizes antigen presentation and memory T-cell generation. These findings show that the mTOR pathway integrates spatiotemporal information of the environmental and cellular energy status by regulating cellular metabolic responses to guide immune cell activation. Elucidation of the metabolic control mechanisms of immune responses will help to generate a systemic understanding of the immune system.
© 2017 Federation of European Biochemical Societies.

Entities:  

Keywords:  T-cell; dendritic cell; glycolysis; immune cell metabolism; lipid metabolism; mTORC1; mTORC2; macrophage; mitochondria

Mesh:

Substances:

Year:  2017        PMID: 28600802      PMCID: PMC6322652          DOI: 10.1002/1873-3468.12711

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  125 in total

Review 1.  SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver.

Authors:  Jay D Horton; Joseph L Goldstein; Michael S Brown
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

2.  HIF-1alpha is essential for myeloid cell-mediated inflammation.

Authors:  Thorsten Cramer; Yuji Yamanishi; Björn E Clausen; Irmgard Förster; Rafal Pawlinski; Nigel Mackman; Volker H Haase; Rudolf Jaenisch; Maripat Corr; Victor Nizet; Gary S Firestein; Hans Peter Gerber; Napoleone Ferrara; Randall S Johnson
Journal:  Cell       Date:  2003-03-07       Impact factor: 41.582

3.  The CD28 signaling pathway regulates glucose metabolism.

Authors:  Kenneth A Frauwirth; James L Riley; Marian H Harris; Richard V Parry; Jeffrey C Rathmell; David R Plas; Rebecca L Elstrom; Carl H June; Craig B Thompson
Journal:  Immunity       Date:  2002-06       Impact factor: 31.745

4.  PI3K-mediated negative feedback regulation of IL-12 production in DCs.

Authors:  Taro Fukao; Masanobu Tanabe; Yasuo Terauchi; Takayuki Ota; Satoshi Matsuda; Tomoichiro Asano; Takashi Kadowaki; Tsutomu Takeuchi; Shigeo Koyasu
Journal:  Nat Immunol       Date:  2002-08-05       Impact factor: 25.606

5.  PKB/Akt induces transcription of enzymes involved in cholesterol and fatty acid biosynthesis via activation of SREBP.

Authors:  Thomas Porstmann; Beatrice Griffiths; Yuen-Li Chung; Oona Delpuech; John R Griffiths; Julian Downward; Almut Schulze
Journal:  Oncogene       Date:  2005-09-29       Impact factor: 9.867

6.  Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis.

Authors:  Li Ma; Zhenbang Chen; Hediye Erdjument-Bromage; Paul Tempst; Pier Paolo Pandolfi
Journal:  Cell       Date:  2005-04-22       Impact factor: 41.582

7.  CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms.

Authors:  Richard V Parry; Jens M Chemnitz; Kenneth A Frauwirth; Anthony R Lanfranco; Inbal Braunstein; Sumire V Kobayashi; Peter S Linsley; Craig B Thompson; James L Riley
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

8.  Mechanism of ribosomal p70S6 kinase activation by granulocyte macrophage colony-stimulating factor in neutrophils: cooperation of a MEK-related, THR421/SER424 kinase and a rapamycin-sensitive, m-TOR-related THR389 kinase.

Authors:  Jason A Lehman; Victor Calvo; Julian Gomez-Cambronero
Journal:  J Biol Chem       Date:  2003-05-11       Impact factor: 5.157

9.  HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia.

Authors:  Jung-whan Kim; Irina Tchernyshyov; Gregg L Semenza; Chi V Dang
Journal:  Cell Metab       Date:  2006-03       Impact factor: 27.287

10.  mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways.

Authors:  Pradip K Majumder; Phillip G Febbo; Rachel Bikoff; Raanan Berger; Qi Xue; Louis M McMahon; Judith Manola; James Brugarolas; Timothy J McDonnell; Todd R Golub; Massimo Loda; Heidi A Lane; William R Sellers
Journal:  Nat Med       Date:  2004-05-23       Impact factor: 53.440

View more
  82 in total

Review 1.  The "other" mTOR complex: New insights into mTORC2 immunobiology and their implications.

Authors:  Helong Dai; Angus W Thomson
Journal:  Am J Transplant       Date:  2019-03-19       Impact factor: 8.086

2.  Inactivation of mTORC2 in macrophages is a signature of colorectal cancer that promotes tumorigenesis.

Authors:  Karl Katholnig; Birgit Schütz; Stephanie D Fritsch; David Schörghofer; Monika Linke; Nyamdelger Sukhbaatar; Julia M Matschinger; Daniela Unterleuthner; Martin Hirtl; Michaela Lang; Merima Herac; Andreas Spittler; Andreas Bergthaler; Gernot Schabbauer; Michael Bergmann; Helmut Dolznig; Markus Hengstschläger; Mark A Magnuson; Mario Mikula; Thomas Weichhart
Journal:  JCI Insight       Date:  2019-10-17

Review 3.  Translational Control in Cancer.

Authors:  Nathaniel Robichaud; Nahum Sonenberg; Davide Ruggero; Robert J Schneider
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-07-01       Impact factor: 10.005

4.  mTOR Dysregulation by Vaccinia Virus F17 Controls Multiple Processes with Varying Roles in Infection.

Authors:  Nathan Meade; Melvin King; Joshua Munger; Derek Walsh
Journal:  J Virol       Date:  2019-07-17       Impact factor: 5.103

5.  Altered mTORC1 signalling may contribute to macrophage dysregulation in hidradenitis suppurativa.

Authors:  Valerio De Vita
Journal:  Inflamm Res       Date:  2017-11-11       Impact factor: 4.575

Review 6.  Lipid Metabolism in Tumor-Associated Natural Killer Cells.

Authors:  Yu Chen; Meihua Sui
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  The evolutionarily conserved MAPK/Erk signaling promotes ancestral T-cell immunity in fish via c-Myc-mediated glycolysis.

Authors:  Xiumei Wei; Yu Zhang; Cheng Li; Kete Ai; Kang Li; Huiying Li; Jialong Yang
Journal:  J Biol Chem       Date:  2020-01-29       Impact factor: 5.157

Review 8.  The role of nitric oxide in metabolic regulation of Dendritic cell immune function.

Authors:  Phyu M Thwe; Eyal Amiel
Journal:  Cancer Lett       Date:  2017-10-26       Impact factor: 8.679

Review 9.  Competitive glucose metabolism as a target to boost bladder cancer immunotherapy.

Authors:  Julieta Afonso; Lúcio L Santos; Adhemar Longatto-Filho; Fátima Baltazar
Journal:  Nat Rev Urol       Date:  2020-01-17       Impact factor: 14.432

10.  Effects of rapamycin on growth hormone receptor knockout mice.

Authors:  Yimin Fang; Cristal M Hill; Justin Darcy; Adriana Reyes-Ordoñez; Edwin Arauz; Samuel McFadden; Chi Zhang; Jared Osland; John Gao; Tian Zhang; Stuart J Frank; Martin A Javors; Rong Yuan; John J Kopchick; Liou Y Sun; Jie Chen; Andrzej Bartke
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-29       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.